Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
about
Genomic ancestry of North Africans supports back-to-Africa migrationsLRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site statusThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseA Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsLRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.The genetic background of Parkinson's disease: current progress and future prospects.Parkinson's disease: from genetics to treatments.Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.LRRK2 dephosphorylation increases its ubiquitination.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review.
P2860
Q21144938-788095B7-9159-41B3-B550-17FE17C1D41CQ24300605-FA4B9BA4-89F8-4319-AD99-F9167EA9F9E4Q26853537-B1D6005F-CE43-470A-92F3-03CFF2C03283Q30235844-E1456DC3-2E80-4391-B263-237E24D7366DQ33561039-5C1A88C9-D0AE-41DF-9CED-18B74D7A570BQ33767528-A94B65EC-1FF7-4099-AAAB-A042062B7235Q34513714-21BBE6E9-A00E-4B01-8D4B-98F91AD6DF83Q38057859-AF659A21-4A9F-4C2E-A541-C5FFF42960F4Q38671888-78CC41D7-A47D-4742-B8C4-AE657BC00F66Q38738200-526DAE92-E65C-4CF0-84C8-BBD3C0F70868Q39288784-A3DCDE33-E2A9-4680-A5E1-C2F1A04226E3Q41785779-F31D940D-BB62-4C25-9F49-BD70B1140582Q54114687-80C08242-AFDC-453A-B8AF-B5885A1DCB36Q54571312-C0A0F3E1-5D21-42A3-BA59-A341A993439AQ55410950-2494AF4C-8956-4BD3-8E59-122FFD1494EB
P2860
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Parkinson's disease-related LR ...... t mutational events in humans.
@ast
Parkinson's disease-related LR ...... t mutational events in humans.
@en
Parkinson's disease-related LR ...... t mutational events in humans.
@nl
type
label
Parkinson's disease-related LR ...... t mutational events in humans.
@ast
Parkinson's disease-related LR ...... t mutational events in humans.
@en
Parkinson's disease-related LR ...... t mutational events in humans.
@nl
prefLabel
Parkinson's disease-related LR ...... t mutational events in humans.
@ast
Parkinson's disease-related LR ...... t mutational events in humans.
@en
Parkinson's disease-related LR ...... t mutational events in humans.
@nl
P2093
P50
P356
P1476
Parkinson's disease-related LR ...... t mutational events in humans.
@en
P2093
A Nazli Basak
Anat Bar-Shira
Anne-Marie Ouvrard-Hernandez
Caroline Pirkevi
Christel Condroyer
Cécile Cazeneuve
Ebba Lohmann
Hiroyuki Tomiyama
Jonathan Carr
Meriem Tazir
P304
P356
10.1093/HMG/DDQ081
P50
P577
2010-03-02T00:00:00Z